Category Archives: Wholesale Pharmacy

PARSIPPANY, N.J., Sept. 21, 2012 /PRNewswire/ --Watson Laboratories, Inc. today issued a voluntary nationwide recall for two lots of Hydrocodone Bitartrate and APAP Tablets, USP 10 mg/500 mg. A customer complaint was received for tablets that were thicker and darker shade than the other tablets. It is possible that some tablets from lots 519406A and 521759A exceed the weight specification and may contain higher than indicated amounts of the ingredients Hydrocodone Bitartrate and/or Acetaminophen. Unintentional ingestion of excessive amounts of acetaminophen may potentially result in an adverse event, including liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than 3 alcoholic beverages a day. The product label warns consumers that acetaminophen overdose can potentially cause severe liver damage, at times resulting in liver transplant or death. Unintentional ingestion of excessive amounts of hydrocodone may result in an adverse event, including an increase in the severity or frequency of side effects, such as sedation or respiratory depression, particularly in patients who are elderly, have severe kidney or liver impairment, or are also taking interacting medications, for example other sedating medications or certain antidepressants. No reports of injuries related to the recalled … Continue reading →

PHOENIX (CBS5) - The nation's largest drug wholesaler is the target of an Arizona lawsuit alleging the company artificially inflating the prices of more than 400 brand-name prescription drugs, costing consumers millions of dollars. The complaint wasfiledon Fridayin Maricopa County Superior Court againstMcKesson Corporation, alleging it violated Arizona's Consumer Fraud Act. [Click here to read the entire complaint (PDF)] Among the drugs that are alleged to have been marked-up inappropriately are: The complaint alleges that several of McKesson's executives constructed a scheme beginning in 2000 to mark up the average wholesale price of many prescription drugs, resulting in higher prescription costs for Arizona businesses and consumers. Thesuit specifically alleges that McKesson raised the spread between the published average wholesale price and the actual acquisition costs in an effort to increase profits for its pharmacy customers, Horne said.Those prices were passed along, the complaint alleges, to third-party payors and consumers. McKesson distributes pharmaceuticals to retailers including Albertson's, Costco, Safeway, Target, Walmart and Walgreens. McKesson controls approximately one-third of the national wholesale drug distribution market. The complaint seeks civil penalties of up to $10,000 against McKesson for each violation of the Consumer Fraud Act, as well as restitution. Copyright 2012 CBS 5 … Continue reading →

ALLIANCE Boots, the owner of Europe's largest pharmacy chain, will buy 12 percent in China's Nanjing Pharmaceutical Co for about 56 million pounds (US$91 million), Alliance said in a statement yesterday. The deal, initially announced over a year ago, will strengthen Alliance Boots' ties with China's government and regulators. Alliance Boots Executive Chairman Stefano Pessina said China is committed to improving its health care sector. Pessina, who turned his family's wholesale pharmaceutical company in Italy into a business empire through a blizzard of mergers and acquisitions, is now eying 20-30 percent of the Chinese pharmaceutical distribution market. "In 10 years, I hope we will be one of the major players in China or we will be, together with other companies, part of one of the major players in China," Pessina said. Shanghai-listed Nanjing Pharmaceutical is China's fifth-largest pharmaceutical wholesaler, with sales of about 20 billion yuan (US$3.2 billion) in 2011, and has a market capitalization of US$682 million. The Jiangsu Province-based company has distribution centers in 12 cities across eight provinces and one autonomous region. Alliance Boots will become Nanjing Pharmaceutical's second-largest shareholder with board representation after the deal, which is conditional on regulatory approvals. It first entered the Chinese … Continue reading →

HONG KONG, Sept 16 Alliance Boots, the owner of Europes largest pharmacy chain, will buy a 12 per cent stake in Chinas Nanjing Pharmaceutical Co Ltd for about 56 million (RM273.8 million), Alliance said in a statement today. The deal, initially announced more than a year ago, will strengthen Alliance Boots ties with Chinas government and regulators. Alliance Boots executive chairman Stefano Pessina told Reuters in an interview that China was committed to improving its healthcare sector. Pessina, who turned his familys wholesale pharmaceutical company in Italy into a business empire through a blizzard of mergers and acquisitions, is now eyeing 20-30 per cent of the Chinese pharmaceutical distribution market. In 10 years, I hope we will be one of the major players in China or we will be, together with other companies, part of one of the major players in China, Pessina said. Alliance Boots is 45 per cent owned by US-based Walgreen Co . Shanghai-listed Nanjing is Chinas fifth-largest pharmaceutical wholesaler, with sales of around 20 billion yuan (RM9.5 billion) in 2011, and has a market capitalisation of US$682 million (RM2.1 billion). Nanjing, based in Jiangsu, has distribution centres in 12 cities across eight provinces and one autonomous … Continue reading →

NANJING, China, Sept. 16, 2012 /PRNewswire/ -- Alliance Boots( http://www.allianceboots.com ), under the terms of a strategic alliance agreement signed today, announces that it will acquire a 12% stake in Nanjing Pharmaceutical Company Limited( http://www.njyy.com ), through a private placement, for a total consideration of approximately EUR56 million (RMB560 million). On completion of the transaction, which is subject to various regulatory approvals, Alliance Boots will be the second largest shareholder in Nanjing Pharmaceutical Company Limited with Board and operational management representation. (Photo: http://www.prnasia.com/sa/2012/09/16/20120916190249726236.html ) (Photo: http://www.prnasia.com/sa/2012/09/16/20120916190902623427.html ) (Photo: http://www.prnasia.com/sa/2012/09/16/20120916190917574062.html ) Nanjing Pharmaceutical Company Limited, which is listed on the Shanghai Stock Exchange, is the fifth largest pharmaceutical wholesaler in China with sales of around EUR2 billion (RMB20 billion) in 2011. It has a strong market position in its home province of Jiangsu operating distribution centres in 12 cities across eight provinces and one autonomous region. Its largest shareholder is Nanjing Pharmaceutical Group Limited. The strategic alliance agreement was signed by Stefano Pessina, Executive Chairman, Alliance Boots, and Zhou Yaoping, Chairman, Nanjing Pharmaceutical Company Limited, after being greeted by Yang Weize, Secretary of Nanjing Municipal CPC Committee. The official ceremony, which took place in the city of Nanjing, was held in … Continue reading →

(Corrects headline to say investing in a wholesaler, not a retailer) HONG KONG, Sept 16 (Reuters) - Alliance Boots, the owner of Europe (Chicago Options: ^REURUSD - news) 's largest pharmacy chain, will buy a 12 percent stake in China's Nanjing Pharmaceutical Co Ltd for about 56 million pounds ($91 million), Alliance said in a statement on Sunday. The deal, initially announced more than a year ago, will strengthen Alliance Boots' ties with China's government and regulators. Alliance Boots Executive Chairman Stefano Pessina told Reuters in an interview China is committed to improving its healthcare sector. Pessina, who turned his family's wholesale pharmaceutical company in Italy into a business empire through a blizzard of mergers and acquisitions, is now eyeing 20-30 percent of the Chinese pharmaceutical distribution market. "In 10 years, I hope we will be one of the major players in China or we will be, together with other companies, part of one of the major players in China," Pessina said. Alliance Boots is 45 percent owned by U.S.-based Walgreen Co (NYSE: WAG - news) . Shanghai-listed Nanjing is China's fifth-largest pharmaceutical wholesaler, with sales of around 20 billion yuan ($3.2 billion) in 2011, and has a market capitalisation … Continue reading →

Posted on September 16, 2012, Sunday THE upcoming emart One Stop Shopping Mall in Batu Kawa, Kuching will be a showcase of an ideal shopping environment where customers can shop comfortably and conveniently. Taking two years, Phase One of the project starts in quarter four of next year for emart One Stop Shopping Mall, while Phase Two for the shoplots is projected to be completed in quarter two of 2014. emart One Stop Shopping Mall will be the anchor business for a strategic and fast-developing area along Mile 4.5 to Bau. There are four schools, five colleges and three universities within close proximity on an area spread over 22.5 acres with more than 1,600 car parking bays. There is an existing population base of over 20,000 residents mostly from the middle and lower income group. emart One Stop Shopping Mall covers 8.9 acres, 75 per cent of which will be air-conditioned, with over 300 retail outlets, a halal food court and emart supermarket, which will take up 75,000 square feet on the ground floor. There will also be non-halal eateries at the shophouses around the mall. Within the mall, there will be a large-scale clean and hygienic hawker centre for … Continue reading →

By Amy Pavuk, Orlando Sentinel The U.S. Drug Enforcement Administration on Friday banned a Walgreens distribution center in Jupiter from dispensing controlled substances to its pharmacies in Florida and the East Coast, saying the business constituted an "imminent danger" to the public. The DEA said that since 2009, the Jupiter distribution center has been the single-largest distributor of oxycodone products in Florida. An immediate suspension order alleges the distribution center did not have effective controls against the illegal use of controlled substances, DEA reports. The suspension order alleges the facility failed to conduct due diligence "to ensure that the controlled substances were not diverted into other than legitimate channels." "The diversion of pharmaceutical controlled substances is a great concern for the DEA," Mark R. Trouville, the Special Agent in Charge of the Miami division said in a statement. "All DEA Registrants have an obligation to ensure that medications are getting into the hands of legitimate patients, and when they choose to look the other way patients suffer and drug dealers prosper," he stated. "The Miami Field Division will continue to investigate all those who contribute to this intolerable situation and deal with them accordingly." In a statement issued Friday, Walgreens … Continue reading →

NEW YORK, NY--(Marketwire - Sep 13, 2012) - http://www.ShinesRooms.com has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Medical Equipment Wholesale industry and are offering free analytical research on Patterson Companies Inc. ( NASDAQ : PDCO ) and PSS World Medical Inc. ( NASDAQ : PSSI ). Register with us now to have free access to these research reports. Simply click on the link below. http://www.ShinesRooms.com/index.php?_controller=RegisterMember&_method=index Macroeconomic headwinds continue to badger companies in the medical equipment wholesale industry. However, several companies have been doing a good job of growing sales as of late. Companies with a broad geographical reach have benefited from their exposure to growing emerging markets, and several companies have also been able to land lucrative contracts as of late. Get your free reports on Patterson Companies Inc. and PSS World Medical Inc. at http://www.ShinesRooms.com/index.php?_controller=RegisterMember&_method=index. There is no commitment to join. ShinesRooms.com is the Ultimate Trading Environment for investors. If you are considering owning Patterson Companies Inc. and PSS World Medical Inc. then you should sign up for a free membership and our complimentary reports today. Over the last 5 years our returns … Continue reading →

Some tablets exceed the weight specification and could be super-potent for the ingredients Hydrocodone Bitartrate and Acetaminophen. The recall includes the following product lot: Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg, NDC 0603-3888-21, 100 count, Lot Number C1440512A, expiry date 12/13. It is possible that some tablets from lot C1440512A exceed the weight specification and could be super-potent for the ingredients Hydrocodone Bitartrate and Acetaminophen. Bottles from the affected lot may contain tablets that have a higher dosage of acetaminophen, and as a result, it is possible that consumers could take more than the intended acetaminophen dose. Unintentional administration of tablets with increased acetaminophen content could result in liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than 3 alcoholic beverages a day. The product label warns consumers that acetaminophen overdose can potentially cause severe liver damage, at times resulting in liver transplant or death. Taking a higher dose of hydrocodone than intended could result in an increase in the severity or frequency of side effects, such as sedation or respiratory depression, particularly in patients who are elderly, have severe kidney or liver impairment, or are also taking … Continue reading →